PISCATAWAY, N.J, April 1, 2020 /PRNewswire/ -- GenScript, a world leading biotechnology company, today announced the commercial launch of its neoantigen peptide synthesis service for biotech and ...
GenScript now offers fast-track cGMP neoantigen peptide and peptide active pharmaceutical ingredients (API) from its new life-sciences manufacturing facility in Zhenjiang, leveraging its long history ...
GenScript's new life-science building in Zhenjiang, Jiangsu, China spans 91,310 sq. ft. and is ISO 9001 certified; highly automated clean-room facilities offer fast-turnaround, high-purity ...
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager ...
GenScript Biotech Corp. has expanded its research capabilities overseas with a new life sciences facility in China, the Piscataway-headquartered company announced May 18. Located in the city of ...
In prominent research fields such as immunotherapy, vaccine development, drug discovery, and proteomics, target screening is frequently carried out using peptide libraries, which are systematic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback